The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
The Role of Intestinal Microbiota in Metastatic Colorectal Cancer Patients Treated With Capecitabine
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The negative impact probably resulted in the damage to the gut barrier and poor control of tumor progression at an advanced stage50.”
From Combining gut microbiota modulation and chemotherapy by capecitabine-loaded prebiotic nanoparticle improves colorectal cancer therapy (2023) · cites this paper as [50]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Analysis of composition of microbiomes: a novel method for studying microbial composition
Mandal, S., Van Treuren, W., White, R. A., Eggesbø, M., Knight, R., & Peddada, S. D. (2015) · Microbial Ecology in Health & Disease · doi:10.3402/mehd.v26.27663 · Cited by 1,942
Flagged first, then by citations
Research works printed but not linked: 33
- Rawla, 2019, Epidemiology of colorectal cancer: incidence, mortality, survival, and risk factors, Prz Gastroenterol, 14, 89
- Cunningham, 2013, Bevacizumab plus capecitabine versus capecitabine alone in elderly patients with previously untreated metastatic colorectal cancer (AVEX): an open-label, randomised phase 3 trial, Lancet Oncol, 14, 1077, 10.1016/S1470-2045(13)70154-2 · DOI
- Hoff, 2001, Comparison of oral capecitabine versus intravenous fluorouracil plus leucovorin as first-line treatment in 605 patients with metastatic colorectal cancer: results of a randomized phase III study, J Clin Oncol, 19, 2282, 10.1200/JCO.2001.19.8.2282 · DOI
- Van Cutsem, 2000, Capecitabine, an oral fluoropyrimidine carbamate with substantial activity in advanced colorectal cancer: results of a randomized phase II study, J Clin Oncol, 18, 1337, 10.1200/JCO.2000.18.6.1337 · DOI
- 2019, A review of 10 years of human microbiome research activities at the US National Institutes of Health, Fiscal Years 2007-2016, Microbiome, 7, 31, 10.1186/s40168-019-0620-y · DOI
- Helmink, 2019, The microbiome, cancer, and cancer therapy, Nat Med, 25, 377, 10.1038/s41591-019-0377-7 · DOI · Paper page
- Sougiannis, 2019, Impact of 5 fluorouracil chemotherapy on gut inflammation, functional parameters, and gut microbiota, Brain Behav Immun, 80, 44, 10.1016/j.bbi.2019.02.020 · DOI
- An, 2016, Combination therapy of lactobacillus plantarum supernatant and 5-fluouracil increases chemosensitivity in colorectal cancer cells, J Microbiol Biotechnol, 26, 1490, 10.4014/jmb.1605.05024 · DOI
- Yuan, 2018, The influence of gut microbiota dysbiosis to the efficacy of 5-Fluorouracil treatment on colorectal cancer, Biomed Pharmacother, 108, 184, 10.1016/j.biopha.2018.08.165 · DOI
- Zimmermann, 2019, Mapping human microbiome drug metabolism by gut bacteria and their genes, Nature, 570, 462, 10.1038/s41586-019-1291-3 · DOI · Paper page
- Aarnoutse, 2019, The clinical link between human intestinal microbiota and systemic cancer therapy, Int J Mol Sci, 20, 4145, 10.3390/ijms20174145 · DOI
- Li, 2020, Composition of fecal microbiota in low-set rectal cancer patients treated with FOLFOX, Ther Adv Chronic Dis, 11, 10.1177/2040622320904293 · DOI
- Aarnoutse, 2017, Study protocol on the role of intestinal microbiota in colorectal cancer treatment: a pathway to personalized medicine 2.0, Int J Colorectal Dis, 32, 1077, 10.1007/s00384-017-2819-3 · DOI
- Aarnoutse, 2017, Study protocol on the role of intestinal microbiota in colorectal cancer treatment: a pathway to personalized medicine 2.0, Int J Colorectal Dis, 32, 1077, 10.1007/s00384-017-2819-3 · DOI
- Eisenhauer, 2009, New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1), Eur J Cancer, 45, 228, 10.1016/j.ejca.2008.10.026 · DOI · Paper page
- Liu, 2020, Evaluation of Compatibility of 16S rRNA V3V4 and V4 Amplicon Libraries for Clinical Microbiome Profiling, bioRxiv
- Galazzo, 2020, How to count our microbes? the effect of different quantitative microbiome profiling approaches, Front Cell Infect Microbiol, 10, 403, 10.3389/fcimb.2020.00403 · DOI
- Callahan, 2016, DADA2: High-resolution sample inference from Illumina amplicon data, Nat Methods, 13, 581, 10.1038/nmeth.3869 · DOI · Paper page
- Lagkouvardos, 2017, Rhea: a transparent and modular R pipeline for microbial profiling based on 16S rRNA gene amplicons, PeerJ, 5, e2836, 10.7717/peerj.2836 · DOI
- GUniFrac, 2018, Generalized UniFrac distances, R package version 1, 1
- McMurdie, 2013, phyloseq: an R package for reproducible interactive analysis and graphics of microbiome census data, PLoS One, 8, e61217, 10.1371/journal.pone.0061217 · DOI
- FGB, 2019, Eduard Szoecs, Wagner aH. vegan: community ecology package, R package version 2.5-6
- Wickham, 2020, dplyr: A grammar of data manipulation, R package version 1.0. 2 (2020)
- Barnett, 2021, microViz: an R package for microbiome data visualization and statistics, J Open Source Software, 6, 3201, 10.21105/joss.03201 · DOI
- Balhareth, 2019, Impact of physical activity and diet on colorectal cancer survivors' quality of life: a systematic review, World J Surg Oncol, 17, 153, 10.1186/s12957-019-1697-2 · DOI
- Sze, 2017, Normalization of the microbiota in patients after treatment for colonic lesions, Microbiome, 5, 150, 10.1186/s40168-017-0366-3 · DOI
- Zwielehner, 2011, Changes in human fecal microbiota due to chemotherapy analyzed by TaqMan-PCR, 454 sequencing and PCR-DGGE fingerprinting, PLoS One, 6, e28654, 10.1371/journal.pone.0028654 · DOI
- Dubinsky, 2020, Predominantly antibiotic-resistant intestinal microbiome persists in patients with pouchitis who respond to antibiotic therapy, Gastroenterology, 158, 610, 10.1053/j.gastro.2019.10.001 · DOI
- Riviere, 2016, Bifidobacteria and butyrate-producing colon bacteria: importance and strategies for their stimulation in the human gut, Front Microbiol, 7, 979, 10.3389/fmicb.2016.00979 · DOI
- Durazzi, 2021, Comparison between 16S rRNA and shotgun sequencing data for the taxonomic characterization of the gut microbiota, Sci Rep, 11, 3030, 10.1038/s41598-021-82726-y · DOI
- Manor, 2020, Health and disease markers correlate with gut microbiome composition across thousands of people, Nat Commun, 11, 5206, 10.1038/s41467-020-18871-1 · DOI
- Reigner, 2001, Clinical pharmacokinetics of capecitabine, Clin Pharmacokinet, 40, 85, 10.2165/00003088-200140020-00002 · DOI
- van Hellemond, 2018, Capecitabine-associated terminal ileitis, Case Rep Oncol, 11, 654, 10.1159/000492781 · DOI
Cited by
Sorted by citations
Lang, T., Zhu, R., Zhu, X., Yan, W., Li, Y., Zhai, Y., Wu, T., Huang, X., Yin, Q., & Li, Y. (2023) · Nature Communications · doi:10.1038/s41467-023-40439-y · Cited by 133
Metadata
- Authors
- Aarnoutse, R., Ziemons, J., de Vos-Geelen, J., Valkenburg-van Iersel, L., Wildeboer, A. C. L., Vievermans, A., Creemers, G.-J. M., Baars, A., Vestjens, H. J. H. M. J., Le, G. N., Barnett, D. J. M., Rensen, S. S., Penders, J., & Smidt, M. L.
- Venue
- Clinical Colorectal Cancer
- Publisher
- Elsevier BV
- Published
- 2022-06
- Volume
- 21
- Issue
- 2
- Pages
- e87-e97
- ISSN
- 1533-0028
- Cited by
- 19
- References
- 1
- Language
- en
- Licence
- Funders
- Servier
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review